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Objectives: To systematically investigate the relationship between motor and non-motor 
symptoms, and health-related quality of life (HR-QoL) in children and young adults with 
dystonia.  
Methods: In this prospective observational cross-sectional study, 60 patients (6-25 years) with 
childhood-onset dystonia underwent a multidisciplinary assessment of dystonia severity 
(Burke-Fahn-Marsden Dystonia Rating Scale, Global Clinical Impression), motor function 
(Gross Motor Function Measure, Melbourne Assessment of Unilateral Upper Limb Function), 
pain (visual analogue scale), intelligence (Wechsler Intelligence Scale), executive functioning 
(Behavior Rating Inventory of Executive Function) and anxiety/depression (Child/Adult 
Behavior Checklist). Measures were analyzed using a principal component analysis and 
subsequent multiple regression to evaluate which components were associated with HR-QoL 
(Pediatric Quality of life Inventory) for total group, and non-lesional (primary) and lesional 
(secondary) subgroups. 
Results: Patients (29 non-lesional, 31 lesional dystonia) had a mean age of 13.6 ± 5.9 years. 
The principal component analysis revealed three components: 1) motor symptoms; 2) 
psychiatric and behavioral symptoms; and 3) pain. HR-QoL was associated with motor 
symptoms and psychiatric and behavioral symptoms (R2=0.66) for the total sample and 
lesional dystonia, but in the non-lesional dystonia subgroup only with psychiatric and 
behavioral symptoms (R2=0.51). 
Conclusions: Non-motor symptoms are important for HR-QoL in childhood-onset dystonia. 
We suggest a multidisciplinary assessment of motor and non-motor symptoms to optimize 
individual patient management.  






Dystonia is a hyperkinetic movement disorder in which sustained or intermittent muscle 
contractions cause abnormal, often repetitive, movements, postures or both.[1] In contrast to 
the mainly idiopathic adult-onset dystonias, childhood dystonia can be caused by a broad 
spectrum of etiologies, the most common being cerebral palsy (CP).[2] In addition, multiple 
heritable causes are known.[3] The wide variety in etiology gives rise to a heterogeneous 
patient population with isolated dystonia or dystonia as part of a complex clinical picture with 
co-existent movement disorders or (non-)neurological features (for example spasticity, 
epilepsy, dysmorhpias, deafness, developmental delay). The dystonia classification system 
enables clinicians to categorize patients.[1] Patients are frequently clustered according to 
etiology, with idiopathic and secondary as main groups.[4] Idiopathic or hereditary dystonia 
patients with no evidence of brain damage are referred to as non-lesional dystonia. In 
addition, there are secondary or lesional dystonias with a cluster including progressive 
dystonia (with neurodegeneration) and static dystonia (associated with structural lesions). 
There is growing interest in non-motor features, such as depression, anxiety, pain and 
selective cognitive impairments (e.g. executive functioning), and their impact on the lives of 
patients.[5] For instance, in adult-onset cervical dystonia patients depression or pain have 
been shown to be more important predictors of the health-related quality of life (HR-QoL) 
than dystonia severity.[6,7] Despite these findings, information relating to the impact of non-
motor symptoms in children and young adults with dystonia is still lacking.  
We therefore performed a systematic multidisciplinary assessment of sixty patients 
with dystonia due to different etiologies. The aim was to explore to what extent motor and 
non-motor symptoms are related to HR-QoL, and to evaluate if the contribution of these 






This cross-sectional study included a total of 60 consecutive referred children and young 
adults with a clinical diagnosis of dystonia. Inclusion criteria were 1) an age between 6 and 26 
years, based on the minimal and maximal age for several outcome measures, and 2) 
childhood-onset dystonia diagnosed by a movement disorders expert. To keep the sample 
representative, the only exclusion criterion was a language barrier between the team and 
patient and/or caregivers.   
Most patients (45) were referred to our dystonia team after visiting the specialized 
multidisciplinary outpatient clinic for movement disorders at the University Medical Center 
Groningen. In addition, fifteen patients were referred from the (pediatric) neurology and 
rehabilitation outpatient clinics. Informed consent or assent was obtained for all participants 
and the study was approved by the local ethics committee (M13.132238). 
Sample size calculation was based on a pilot in fifteen patients. Dystonia severity 
(measured with the Burke-Fahn-Marsden dystonia rating scale, BFMDRS) was the least 
important predictor of HR-QoL with a medium effect size. G*Power was used to calculate 
that to detect an effect size of 0.4 with a power of 0.8 (1-β), 52 patients needed to be included. 
With a drop-out of 10-15%, this led to a sample size of 60 in total.[8]  
Multidisciplinary team members and evaluation 
The team consists of clinicians and allied health professionals within the departments of 
neurology, neuropsychology and rehabilitation, i.e.. neurologists, neuropsychologists, 
rehabilitation doctor, physiotherapist and occupational therapists. Patients visited our hospital 
for a one or two-day systematic multidisciplinary evaluation. This evaluation comprised 
questionnaires regarding HR-QoL, mood, behavior and executive functioning. In addition, 
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quantitative standardized tests were undertaken to evaluate dystonia severity, gross and fine 




Severity of dystonia was determined using the motor subscale of the BFMDRS.[9] Two 
experts (DS, KP) video-rated dystonia extent in nine body regions (eyes, mouth, 
speech/swallowing, neck, upper extremities, trunk and lower extremities) and the total sum 
score was determined.    
The Clinical Global Impression Scale (GCI-S) was also used to rate the severity of 
motor symptoms from normal (1) to extremely impaired (7).[10] The rater scored the GCI-S 
on the total clinical picture, including dystonia and potential co-existent symptoms.  
Motor functioning  
The Gross Motor Function Measure (GMFM-88) was used for the measure of gross motor 
abilities in five settings (lying and rolling, sitting, crawling and kneeling, standing, and 
walking, running and jumping).[11] In a normally developing child, all items can be executed 
at the age of 5.5 years. The test were carried out by a qualified physiotherapist, and the total 
overall score was used for analysis.  
The arm function was measured using the Melbourne Assessment of Upper Limb 
Function (MAULLF) administered by an occupational/hand therapist (RT, ME).[12] This test 
measures the movement range, accuracy, dexterity and fluency of gross and fine motor 
movements separately for each arm, recorded as an overall percentage value (0-100). The 





Pain was assessed using the Numeric Pain Rating Scale (NPRS) on the overall level of pain 
ranging from 0 (no pain) to 10 (worst imaginable pain).[13] When pain was present in more 
than one body area, an average pain score was derived.    
Mood and anxiety 
The presence of depressive and anxiety symptoms was measured with the Child Behavior 
Checklist (CBCL) or Adult Behavior Checklist (ABCL) completed by parents.[14,15] These 
are widely used to identify a broad spectrum of behavioral problems. The internalizing 
problems scale comprises symptoms related to somatic complaints, anxiety, depression and 
social withdrawal related behavior. Scores are given as a normative t-score, in which a score 
of 50-65 was normal range, 65-70 borderline and >70 clinically symptomatic.  
Intelligence quotient 
Intelligence quotient (IQ) was measured with the Wechsler Intelligence Scale for Children 
(WISC-III-NL) or Wechsler Adult Intelligence Scale (WAIS-III-NL).[16,17] Full IQ 
comprises verbal (general knowledge, language, reasoning, and memory skills) and 
performance scores (spatial, sequencing, and problem-solving skills). IQ was scaled as gifted 
(≥130), very high (120-129), bright normal (110-119), average (90-109), low-average (85-89), 
borderline (70-84), mental retardation or intellectual disability (<70).    
Executive functioning 
The Behavior Rating Inventory of Executive Function (BRIEF) is a widely used behavior 
rating scale.[18] It aims to identify potential executive deficits in the fields of inhibition, 
flexibility, emotional control, initiation, working memory, planning and organization, 
organization of materials, and monitoring. The summary score serves as an indicator of global 
executive functioning and was used for analysis. Scores are given as a normative t-score 
within the normal (50-65), borderline (65-70) or clinical range (>70).   
8 
 
Health-related quality of life 
The Dutch Generic Core Scale of the Pediatric Quality of Life Inventory 4.0 (PedsQL) was 
used to determine HR-QoL.[19,20] This validated 23-item, age-adjusted questionnaire asks 
parents to indicate difficulties with physical activity (walking, running, exercise, lifting, self-
care, pain, fatigue), emotion (anxiety, sadness, angriness, sleep, worrying), social interaction 
(getting along, friends, teasing, keeping up with others, playing) and school-related domains 
(attention, memory, schoolwork, missing school) over the past four weeks. Total HR-QoL 
score comprised the mean score the sum of all answers divided by the number of answered 
items and psychosocial functioning was calculated in the same way as for the emotional, 
social and social subscales.  
Statistical analysis 
The statistical analysis of the data was conducted using the PASW 23 Statistics for Windows 
(SPSS Statistics, Chicago, IL, USA) with significance threshold of p <0.05. After testing for 
normal distributions with a Q-Q plot and a Shapiro-Wilk test, distribution was presented as 
mean and standard deviation (SD) or median and interquartile range (IQR) where appropriate.  
Patients were divided into two subgroups according to the underlying etiology.[1,4] In 
order to increase the readability of the manuscript, we chose to use the terms non-lesional 
(primary) and lesional (secondary) dystonia. The idiopathic or hereditary dystonia patients 
without evidence of brain damage were referred to as non-lesional dystonia. To prevent 
overly small subgroups, children and young adults with dystonia due to static lesions or 
neurodegeneration, both hereditary and acquired, were categorized as lesional dystonia. 
Differences in patient characteristics were analyzed using the Pearson Chi-square test or 
Fisher’s exact test or Mann-Whitney U.  
 HR-QoL was compared to a sample of healthy Dutch children published 
previously.[20] To determine predictors of HR-QoL, a principal component analysis (PCA) 
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and subsequent multiple regression analysis was performed. The PCA is an approach to 
reduce the dataset to a manageable size while retaining as much of the original data.[21] By 
looking at associations between variables, the PCA converts initial variables into clusters of 
correlated variables, so-called components. To compensate for potentially correlating 
components, we applied oblique component rotation. Because PCA is a method that explores 
(co)variance, outcome measures were normalized to z-scores before entering the PCA to 
enable direct comparison. Internal consistency of the components was adequate if Cronbach’s 
Alpha >0.7. To check the robustness of the results and the possible influence of missing data, 
a sensitivity analysis with PCA was performed both with excluding cases list wise and pair 
wise to see if it resulted in the same components.     
    For each component derived from the PCA, bootstrapping was conducted as 
sensitivity analysis to test stability of the distribution (see supplement 1). Subsequently, a 
multiple regression with backward elimination was used to calculate to what extent the 
components explained variance in HR-QoL (total PedsQL score). The multiple regression was 





The sixty patients (35M/25F) had a mean age at examination of 13.6 years (SD=5.9) and a 
motor disease duration of 9.6 years (SD=5.1) (Table 1). Fifteen patients were over the age of 
18. The majority had a generalized dystonia (60%), followed by segmental (28%) and hemi 
dystonia (12%). In 25 patients, there was a mixed movement disorder with dystonia as main 
feature. Co-existent neurological or systemic features were present in 34 patients. A genetic 
etiology was identified in 23 patients, involving DYT4 (n=1), DYT6 (n=2), DYT11 (n=9), 
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DYT12 (n=1), Aristaless related homeobox gene (n=1), beta-actin gene (n=1), glutaric 
aciduria type 1 (n=2), Rett syndrome (n=1), methylmalonic acidemia (n=1), RELN (n=2), 
vitamin E deficiency (n=1) and uniparental disomy of chromosome 7 (n=1).  
 Dividing our sample revealed 29 non-lesional and 31 lesional dystonia patients. 
Characteristics differed between groups, with an earlier disease onset (1.5 vs 6.7 years), more 
generalized dystonia (71% vs 48%) and more frequent coexistent neurological or systemic 
features (77% vs 38%) in lesional dystonias.   
Outcome measures 
An overview of the outcome measures is presented in Table 2. Dystonia severity (median 
BFMDRS 38.4, IQR 23.8-90.0) and motor functioning (GMFM median 90% IQR 59.1-100%; 
MAULLF median 80.5% IQR 47.9-98.3%) varied among patients. For non-motor outcomes, 
median pain rate was 4.0 and 33% reported a moderate to severe level of pain (>5). Mean IQ 
score was 88.4 with an intellectual disability in 45% (n=27) of the patients. Twenty-one 
patients had borderline to clinical t-score on the internalizing problems scale of the CBCL and 
four elevated scores on the BRIEF, indicative of executive deficits.   
Missing data on motor tests in Table 2 was because of fatigue or behavioral aspects 
interfering with the tests. In addition, completion of questionnaires relating to mood, behavior 
and executive function was not possible in respectively nine and sixteen patients due to 
developmental delay. Twenty-five patients were not able to undertake the full assessment of 
intelligence due to severe communication difficulties or motor impairment. Total IQ was not 
significantly correlated with HR-QoL in the remainder thirty-five patients (p=0.364). 
However, as a potential bias could not be excluded, IQ was excluded from further analyses.  
When comparing non-lesional and lesional dystonia, children and young adults with 
lesional dystonia had more severe symptoms, reflected in higher scores on the BMFDRS 
(median 89.6 vs 24.6) and GCI-S (median 6.0 vs 4.0) and lower scores on gross motor 
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functioning (GMFM median 59.1% vs 100.0%) and upper limb functioning (MAULLF 
median 60.0% vs 87.3%). Moderate or severe pain was less frequently reported in non-
lesional dystonia patients (24% vs 42%). Elevated scores on internalizing problems were 
found in 47% of the non-lesional patients and 35% of the lesional patients.  
Principal component analysis 
The PCA of the whole group resulted in three principal components (Table 3). The ‘motor 
symptoms’ component comprised the BFMDRS, GCI-s, GMFM and MAULLF scores and 
explained 53% of the variance. The second component was labelled as ‘mood and executive 
function’ and the internalizing subscale on the CBCL/ABCL and total BRIEF score (22% of 
variance). The ‘pain’ component consisted of the NPRS and accounted for 15% of the 
variance. The components did not differ for list wise or pair wise deletion of cases 
(Supplement 1) and showed a sufficient Cronbach’s Alpha coefficient.  
HR-QoL assessment and it’s predictors  
Comparing HR-QoL scores between the whole sample with healthy Dutch children (mean age 
12.1 SD 3.2, 57% boys), revealed substantially lower scores.[20] This was the case for total 
HR-QoL (58.6±20.7 vs 87.6±11.0), as well as physical (49.3±19.6 vs 92.2±9.1) and 
psychosocial domains of functioning (64.0±17.1 vs 88.8±9.7). HR-QoL was not significantly 
correlated with gender or disease duration and showed a mild correlation with age that 
disappeared when corrected for extent of motor symptoms (ρ=0.39; p<0.05 and p=0.364 
respectively). In addition, age did not significantly correlate with the non-motor outcome 
measures (p=0.640-p=840). 
Bootstrapping of the components showed stable distributions (Supplement 1). For the 
total sample, HR-QoL was significantly associated with the motor symptoms, mood and 
executive function and pain (adjusted R2=0.66, p<0.001) (Table 4). In non-lesional dystonia, 
HR-QoL was only significantly associated by mood and executive function (adjusted 
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R2=0.53, p<0.001). For lesional dystonia, motor functioning and mood and executive function 
were predictors (adjusted R2=0.51, p=0.006).   
 
DISCUSSION 
In this study, we showed that the HR-QoL is reported to be substantially low for children and 
young adults with dystonic syndromes. HR-QoL is strongly correlated with motor and non-
motor function (mood, executive functioning and pain). Subgroup analysis revealed motor 
and non-motor influences on HR-QoL in lesional dystonia, whereas mood and executive 
functioning were the only significant predictors in non-lesional dystonia.   
 In our sample we found a significantly lower HR-QoL in comparison to healthy Dutch 
controls that could not be explained solely by the dystonia severity and motor functioning. 
The possible contribution of non-motor symptoms to HR-QoL in childhood dystonia has been 
highlighted, but has never been systematically studied before.[22] Still, treatment strategies 
mainly focus on motor symptoms.[23] Although dystonia severity and motor functioning 
scales may reflect severity of motor symptoms, these outcome parameters should not be 
confused with overall wellbeing of patients. 
Mood and executive functioning were at least as important as motor symptoms for 
perceived HR-QoL. We also found a high prevalence of abnormal depression and anxiety 
scores compared to the general population, suggestive for more frequently present psychiatric 
problems in childhood-onset dystonia. The significance of behavioral problems is in line with 
literature in adult dystonia, where the presence of psychiatry co-morbidity is highly associated 
with a decreased HR-QoL.[6,7] To our knowledge, this is the first systematic report to 
directly link non-motor symptoms to HR-QoL and thereby underscores the necessity to 
systematically evaluate non-motor symptoms in young patients with dystonia to capture the 
true disease burden.  
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Pain is the most frequently reported concern in childhood dystonia.[24,25] Despite the 
presence of moderate to severe pain in a third of our sample, pain seemed a less important 
predictor of HR-QoL. Possibly, the NPRS was not sensitive enough. A recently proposed 
model for the care of young patients with dystonia highlighted these difficulties, proposing 
the assessment of the consequences of pain on daily living rather than directly measure the 
pain in order to capture the perceived impact of pain in this heterogeneous population.[26]  
In our study, we found differences between non-lesional and lesional dystonia 
patients. While non-motor symptoms are important across the whole sample, motor problems 
were only associated with a lower HR-QoL in lesional dystonia patients. This could be partly 
explained by more severe motor symptoms in the lesional dystonia subgroup and the power of 
the study that was based on the total sample. However, 14/29 non-lesional dystonia patients 
had a generalized dystonia with moderate to severe motor impairments, still not leading to a 
significant association with HR-QoL. Studies in adults with non-lesional dystonia also have 
repeatedly shown only fair to absent associations between motor severity and HR-QoL.[6,7] 
Although motor symptoms seem more important in lesional dystonia, clinicians must be 
aware of the possible underlying (non-motor) stressors of these symptoms. The frequently 
overlapping cognitive impairments and/or limited communication abilities in lesional dystonia 
likely limits their ability to express their concerns.[4] An aggravation of motor symptoms may 
be the sole indicator for the presence of a physical or mental stressor. Examples include 
dystonic storms triggered by an ileus or painful dislocated hip.[27,28] As the HR-QoL is not 
associated with motor symptoms in non-lesional dystonia and only partly in lesional 
childhood-onset dystonia, physicians should be more cognizant of non-motor aspects.  
There are several limitations to our study. Firstly, although we kept the inclusion criteria as 
wide as possible, we still do not know exactly to what extent our patient sample reflects the 
population of young patients with childhood-onset dystonic syndromes. We chose to include 
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children and young adults. In the general population, prevalence of emotional disorders tends 
to be lower in children.[29] Given our finding that non-motor symptoms are an important 
determinant of quality of life, it may be queried whether the importance of non-motor 
symptoms was equal across both age groups. In fact we found no relationship between 
severity of non-motor symptoms and age, suggesting that non-motor symptoms are important 
for both children and young adults. Secondly, several of the used outcome measures we used 
are not validated for the study sample. However, the BFMDRS is commonly used in children 
and young adults with dystonia. In addition, the GMFM and MAULLF, originally developed 
for children with CP, have been used in young adults with CP[30] and childhood 
dystonia.[31] We selected widely used measures to ensure it was the most reliable approach to 
compare patients across the whole spectrum of dystonic syndromes. The choice of broad 
outcome measures might have led to overlooked problems in specific areas within these 
domains. However, our aim was to first highlight the presence and importance of different 
(non-)motor features and a more detailed description might be an interesting scope for future 
studies. Lastly, we used questionnaires completed by the patients’ caregivers to measure HR-
QoL, mood and behavior and executive functioning, and as a consequence sensitive for rater 
bias. Moreover, there might be a difference in the perception of problems between patients 
and parents due to a possible impaired self-awareness in patients. However, 33% of the 
patients were unable to complete questionnaires themselves due to an intellectual disability, 
communication difficulties and/or age. This led to missing values, but exclusion of these 
patients would have led to a non-representative subpopulation. Although we are aware of the 
possible differences in interpretation between parents and patients, this was the most 
consistent approach to gather information across the whole population.  
In conclusion, HR-QoL is low in children and young adults with dystonia. In non-
lesional dystonia, this low HR-QoL is influenced by the presence of anxiety and depressive 
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symptoms and problems in executive functioning, whereas in children and young adults with 
lesional dystonia motor symptoms play an additional role. These findings support the 
hypothesis that non-motor symptoms play an important role in the phenotypic characterization 
of the dystonia disease. We suggest a multidisciplinary approach to young patients with 
dystonia to assess both motor functioning and non-motor symptoms to optimize management 
of this patient population.   
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